⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfur Hexafluoride SCHEMBL28080990 | 0.80 | — | — | |
| SCHEMBL44994 | 0.79 | — | — | |
| SCHEMBL27485685 | 0.79 | — | — | |
| Perflutren SCHEMBL23928389 | 0.78 | LMNA (0.35) | — | |
| Ammonia Solution, Strong SCHEMBL18261967 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL4433430 | 0.72 | — | — | |
| SCHEMBL3741599 | 0.72 | — | — | |
| SCHEMBL729133 | 0.72 | — | — | |
| SCHEMBL9101079 | 0.72 | — | — | |
| Iodide SCHEMBL1728387 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-220961397-U | Sulfur hexafluoride gas quality analysis system | 新疆送变电有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-220961397-U | Sulfur hexafluoride gas quality analysis system | 新疆送变电有限公司 | 2024-05-14 | — | — | CN | disclosed |
| US-20200146799-A1 | METHOD OF REMOVING AN INFLATED IMPLANT FROM A BLADDER | SOLACE THERAPEUTICS INC (US) | 2020-05-14 | — | — | US | disclosed |
| EP-1572285-B1 | IMPLANTABLE PRESSURE ATTENUATION DEVICE | SOLACE THERAPEUTICS INC (US) | 2019-08-07 | — | — | EP | disclosed |
| US-20170354491-A1 | DELIVERY SYSTEM FOR INFLATABLE IMPLANT | SOLACE THERAPEUTICS, INC. | 2017-12-14 | — | — | US | disclosed |
| US-9615911-B2 | Delivery system for inflatable implant | ATTENUEX TECHNOLOGIES, INC. (US) | 2017-04-11 | — | — | US | disclosed |
| US-20170079761-A1 | METHOD OF REMOVING AN INFLATED IMPLANT FROM A BLADDER | SOLACE THERAPEUTICS, INC. | 2017-03-23 | — | — | US | disclosed |
| US-20170065160-A1 | METHOD OF REMOVING AN INFLATED IMPLANT FROM A BLADDER | SOLACE THERAPEUTICS, INC. | 2017-03-09 | — | — | US | disclosed |
| US-9427295-B2 | Method of removing an inflated implant from a bladder | SOLACE THERAPEUTICS, INC. | 2016-08-30 | — | — | US | disclosed |
| US-20150366652-A1 | DELIVERY SYSTEM FOR INFLATABLE IMPLANT | SOLACE THERAPEUTICS, INC. | 2015-12-24 | — | — | US | disclosed |
| US-6976951-B2 | High vapor pressure attenuation device | SOLACE THERAPEUTICS, INC. (US) | 2005-12-20 | — | — | US | disclosed |
| US-6976950-B2 | Implantable valved pressure attenuation device | SOLACE THERAPEUTICS, INC. (US) | 2005-12-20 | — | — | US | disclosed |
| EP-1572285-A2 | IMPLANTABLE PRESSURE ATTENUATION DEVICE | Solace Therapeutics, Inc. (US) | 2005-09-14 | — | — | EP | disclosed |
| US-20050187427-A1 | Method of treating benign hypertrophy of the prostate | SOLACE THERAPEUTICS, INC. | 2005-08-25 | — | — | US | disclosed |
| US-20040138520-A1 | High vapor pressure attenuation device | SOLACE THERAPEUTICS, INC. | 2004-07-15 | — | — | US | disclosed |
| WO-2004030518-A2 | IMPLANTABLE PRESSURE ATTENUATION DEVICE | SOLACE THERAPEUTICS, INC. (US) | 2004-04-15 | — | — | WO | disclosed |
| US-20030236442-A1 | Implantable valved pressure attenuation device | SOLACE THERAPEUTICS, INC. | 2003-12-25 | — | — | US | disclosed |
| US-20030229264-A1 | Implantable self-inflating attenuation device | SOLACE THERAPEUTICS, INC. | 2003-12-11 | — | — | US | disclosed |
| US-20030229263-A1 | Treatment of patients with a compressible attenuation device | SOLACE THERAPEUTICS, INC. | 2003-12-11 | — | — | US | disclosed |
| EP-0132407-B1 | ULTRAVIOLET LIGHT ASSISTED FLUORINATION OF POLYMER SURFACES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1988-10-19 | — | — | EP | disclosed |